Table 2. Clinical history in the total cohort and according to stages of Fabry cardiomyopathy.

	Early stage		Intermediate stage		Severe stage
	Baseline (n = 39)	Follow-up (n = 17)	Baseline (n = 23)	Follow-Up (n = 19)	Baseline (n = 12)	Follow-up (n = 10)
Bundle branch block	1 (2.6)	2 (12)	1 (4.3)	2 (10) *	2 (17)	4 (40) †
Cardiac arrhythmia	3 (7.7)	3 (18)	3 (13)	5 (26)	2 (17)	6 (60) †
Angina pectoris without CAD	0	1 (5.8)	0	2 (10) *	1 (8.3)	4 (40) †
ACVB, Stent or ICD	1 (2.6)	1 (5.8)	0	1 (5.3)	2 (17)	2 (20)

Mean observation period of 51 ± 24 months.

* p<0.005 intermediate CM baseline vs. intermediate CM follow-up

† p<0.005 advanced CM baseline vs. advanced CM follow-up

CAD, coronary artery disease

CM, cardiomyopathy

LE, late enhancement

ACVB, aorto-coronary vein bypass

ICD, implanted cardioverter defibrillator.